Condition
EGFR Overexpression clinical trials and research
As of November 12, 2026, Find a Trial lists 2 EGFR Overexpression clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), United States (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
YH32364 for locally advanced or metastatic EGFR‑overexpressing solid tumors
This trial will test whether YH32364 can help adults with advanced or metastatic cancers that overexpress EGFR when other treatments haven't worked.
-
Vaccine therapy for metastatic solid tumors
This study is testing a new vaccine therapy to see if it can safely help people with certain types of advanced breast and stomach cancers fight their tumors better.
Related topics
Quick answers
How many EGFR Overexpression clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.